Sculptor Capital’s Salix Pharmaceuticals SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Sculptor Capital's SLXP Position: Q2 2015 in Review
Sculptor Capital sold out of Salix Pharmaceuticals (SLXP) in Q2 2015, closing a stake of 1,235,563 shares — an estimated $214M sold.
Sculptor Capital first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $214M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- Sculptor Capital reported no remaining Salix Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
- Sculptor Capital sold 1,235,563 Salix Pharmaceuticals shares in Q2 2015, an estimated $214M.
- Sculptor Capital first reported a position in Salix Pharmaceuticals in Q3 2014 and held it in 2 quarters.
- Sculptor Capital's Salix Pharmaceuticals position peaked at $214M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Salix Pharmaceuticals as of Q2 2015.
Based on Sculptor Capital's 13F filing for Q2 2015, filed 14 Aug 2015.